**Core Concept**
Metformin is a biguanide antidiabetic agent primarily used to reduce hepatic glucose production and improve insulin sensitivity in patients with type 2 diabetes mellitus. It does not work in patients without diabetes due to the absence of hyperglycemia and insulin resistance.

**Why the Correct Answer is Right**
Metformin is effective in type 2 diabetics, obese patients with diabetes, and those unresponsive to sulfonylureas. However, in non-diabetics, there is no hyperglycemia or insulin resistance, so metformin has no role in lowering blood sugar. Its mechanism—decreasing hepatic glucose output and improving peripheral insulin sensitivity—only applies in the context of diabetes.

**Why Each Wrong Option is Incorrect**
Option B: Obese diabetics benefit significantly from metformin due to insulin resistance and increased hepatic glucose production.
Option C: Metformin is a first-line treatment for type 2 diabetes and is highly effective in this group.
Option D: In patients failing sulfonylureas, metformin is often added to improve glycemic control and reduce hypoglycemia risk.

**Clinical Pearl / High-Yield Fact**
Metformin is not indicated in non-diabetic individuals because it does not lower blood sugar in the absence of hyperglycemia. It is contraindicated in patients with severe renal impairment and should be used cautiously in those with liver disease.

✓ Correct Answer: A. Non diabetics